Clinical use of dimethyl fumarate in multiple sclerosis treatment: an update to include China, using a modified Delphi method

Dimethyl fumarate (DMF) is a widely used oral disease-modifying therapy for multiple sclerosis (MS). Its efficacy and safety profiles are supported by over a decade of experience. Differences exist between Asia and Europe/United States in the prevalence and characteristics of MS; most data for DMF a...

Descripción completa

Detalles Bibliográficos
Autores principales: Gold, Ralf, Barnett, Michael, Chan, Andrew, Feng, Huiyu, Fujihara, Kazuo, Giovannoni, Gavin, Montalbán, Xavier, Shi, Fu-Dong, Tintoré, Mar, Xue, Qun, Yang, Chunsheng, Zhou, Hongyu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2023
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10350766/
https://www.ncbi.nlm.nih.gov/pubmed/37465201
http://dx.doi.org/10.1177/17562864231180734

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10350766/
https://www.ncbi.nlm.nih.gov/pubmed/37465201
http://dx.doi.org/10.1177/17562864231180734

Ejemplares similares